Skip to content

Clinical trials

Terminated Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Terminated Clear all

322 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20024
20031
200410
200513
200620
200724
200823
200921
201015
201113
201211
201312
201413
201518
201618
201720
201812
20199
202010
202120
202214
20237
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated322

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center28
Masonic Cancer Center, University of Minnesota18
Fred Hutchinson Cancer Center12
Novartis Pharmaceuticals10
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins7
Celgene5
Incyte Corporation5
National Cancer Institute (NCI)5
OHSU Knight Cancer Institute5
Bellicum Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes322
Leukemia, Myeloid, Acute166
Leukemia108
Precursor Cell Lymphoblastic Leukemia-Lymphoma91
Multiple Myeloma68
Leukemia, Myelomonocytic, Chronic62
Lymphoma60
Lymphoma, Non-Hodgkin59
Leukemia, Lymphocytic, Chronic, B-Cell58
Hodgkin Disease49

Trials

Showing 76 to 100 of 322. Each trial links to its page on Pharma Observatory.

222 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.